Dividend compounder review

SCLP

Scancell Holdings plc · LSE · GB

Healthcare · Biotechnology

Score26.00/100
Confidence67.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 7.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 8.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 1.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 10.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income£-5.9M
Free Cash Flow£-15.8M
FCF Covers DividendUnknown
Debt / Equity-
P/E-
Revenue Growth 5Y-
Net Margin-117.0%
ROE-
Price vs Trend41.6%
3Y Return45.6%
5Y Return-12.3%
CurrencyGBP
Warnings

Review flags

No usable dividend history found.
Free cash flow is negative.
Dividend diary

Activity record

SCLP dividend review warning Warning · Warning

Free cash flow is negative.